Selection of IgG properties for therapeutic applications

Add to your list(s) Download to your calendar using vCal

• Dr Mike Clark, Department of Pathology, Cambridge
• Wednesday 03 October 2012, 12:30-13:30
• Lecture Theatre, Department of Pathology, Tennis Court Road.

If you have a question about this talk, please contact Sue Griffin.

Host: Jim Kaufman (jfk31@cam.ac.uk)

This talk will give the background and an overview to work on the selection and engineering of IgG Fc regions for therapeutic applications.

Examples will include selection of Fc regions for the commercially developed antibodies alemtuzumab (CD52), otelixizumab (CD3) and tanezumab (NGF), as well as antibodies to the red cell antigen RhD, and the platelet alloantigen HPA -1a.

This talk is part of the Immunology in Pathology series.

This talk is included in these lists:

• Biology
• Cambridge Immunology
• Cambridge Infectious Disease
• Cambridge Infectious Diseases
• Lecture Theatre, Department of Pathology, Tennis Court Road
• Life Sciences
• Life Sciences
• ME Seminar
• Pathology Seminars
• my_list
• other talks

Note that ex-directory lists are not shown.